ASH 59th Annual Meeting and Exposition
From December 9-12, the American Society of Hematology will be hosting its Annual Meeting and Exposition in Atlanta, Georgia. The meeting will provide an opportunity to review thousands of scientific abstracts highlighting updates in the hottest topics in hematology as well as to network with top minds in the field. Journal of Clinical Pathways will be covering the most relevant abstracts leading up to the meeting, as well as many of the live sessions during the meeting.
Earlier access to palliative care may increase the likelihood that patients with hematologic malignancies nearing end-of-life can die at home.
More than one-fifth of patients undergoing hematopoietic cell transplantation reported a lack of awareness of financial burden prior to the procedure.
A single-agent therapy conferred a favorable safety profile and exhibited evidence of durable responses in patients with heavily pretreated relapsed and refractory multiple myeloma.
Hospice use among multiple myeloma patients at the end of life has steadily increased over time.
Prognosis and cure perceptions among older adults with acute myeloid leukemia often diverge from oncologist estimates.
Palliative care utilization among patients with hematologic malignancies remains extremely low.
Patients with acute leukemia exhibited a high rate of venous thromboembolism, along with high recurrence rates.
Patients with sickle cell disease who are insured through Medicaid used hematology care services at a far lower rate than commercially insured patients.